2023
DOI: 10.1016/j.heliyon.2023.e13637
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and tuberculosis coinfection: An overview of case reports/case series and meta-analysis of prevalence studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 69 publications
1
12
0
2
Order By: Relevance
“…Recent reports showed that the prevalence of G1 infection (past or current) was about 1.1%% in COVID-19 patients [17]. Our results included the following: likelihood ratio in the CNM model is 311; the post-test probability is 77.3% in a prevalence of 1.1% of hospitalized patients with underlying diseases having the impact on the outcome of the COVID-19.…”
Section: Strengthmentioning
confidence: 65%
“…Recent reports showed that the prevalence of G1 infection (past or current) was about 1.1%% in COVID-19 patients [17]. Our results included the following: likelihood ratio in the CNM model is 311; the post-test probability is 77.3% in a prevalence of 1.1% of hospitalized patients with underlying diseases having the impact on the outcome of the COVID-19.…”
Section: Strengthmentioning
confidence: 65%
“…Mechanisms may include increased lung damage in TB patients with COVID-19, resulting in impaired lung function ( 202 ) or higher risk of TB reactivation after COVID-19 infection due to depletion of CD4 T cells and excessive lung fibrosis. Worse outcomes of co-infection may also be because of shared clinical, immunological, and social determinants ( 203 206 ), as well as compromised linkage to care for HIV and TB in a pandemic environment ( 207 ). In our own South Africa based cohort of SARS-CoV-2 infected individuals, we did not observe a clear enrichment of active TB disease ( 208 ) relative to the observed incidence in the South African population ( 209 ).…”
Section: Mtb and Sars-cov-2 Co-infectionmentioning
confidence: 99%
“…Studies from Turkey described the clinical features of 16 patients with co‐infection, highlighting the need for careful management and monitoring of these individuals (Gül et al., 2022 ). However, the overall prevalence of TB and COVID‐19 co‐infection appears to be relatively low (Daneshvar et al., 2023 ). Impact on TB mortality and adverse outcomes: the association between TB and COVID‐19 mortality/adverse outcomes is still not fully understood.…”
Section: Introductionmentioning
confidence: 99%
“…Studies from Turkey described the clinical features of 16 patients with co‐infection, highlighting the need for careful management and monitoring of these individuals (Gül et al., 2022 ). However, the overall prevalence of TB and COVID‐19 co‐infection appears to be relatively low (Daneshvar et al., 2023 ).…”
Section: Introductionmentioning
confidence: 99%